Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-05-27

Clinical Trial Update: The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)

View source ↗

Summary

This document discusses the roles of angiopoietin, Tie-2, and VEGF in sepsis-induced multiple organ dysfunction syndrome and references a clinical trial (NCT009…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Sepsis, Multiple Organ Dysfunction Syndrome | Status: UNKNOWN